Growth Metrics

Allurion Technologies (ALUR) Short term Debt (2022 - 2024)

Allurion Technologies posted quarterly Short term Debt of $39.0 million for Q1 2024, up 0.81% on a QoQ basis from $38.6 million in Q4 2023.

Allurion Technologies (ALUR) has 3 years of Short term Debt data on file, last reported at $39.0 million in Q1 2024.

  • For the quarter ending Q1 2024, Short term Debt changed N/A year-over-year to $39.0 million; the trailing twelve-month figure through Mar 2024 stood at $39.0 million (changed N/A YoY), and the FY2023 full-year result was $38.6 million, down 27.58% from the prior year.
  • Short term Debt for Q1 2024 stood at $39.0 million, up from $38.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $57.7 million in Q3 2023 and bottomed at $38.6 million in Q4 2023.
  • The 3-year median for Short term Debt is $53.4 million (2022), against an average of $48.5 million.
  • Peak annual rise in Short term Debt reached 27.58% in 2023, while the deepest fall reached 27.58% in 2023.
  • A 3-year view of Short term Debt shows it stood at $53.4 million in 2022, then decreased by 27.58% to $38.6 million in 2023, then grew by 0.81% to $39.0 million in 2024.
  • The last three Short term Debt figures came in at $39.0 million (Q1 2024), $38.6 million (Q4 2023), and $57.7 million (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Allurion Technologies - - 1.23 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 38.96 Mn
Dec 31, 2023 38.64 Mn
Sep 30, 2023 57.68 Mn
Jun 30, 2023 53.67 Mn
Dec 31, 2022 53.36 Mn